GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharmaceuticals Industries Ltd (BOM:524715) » Definitions » Accounts Receivable

Sun Pharmaceuticals Industries (BOM:524715) Accounts Receivable : ₹0 Mil (As of Dec. 2023)


View and export this data going back to 1994. Start your Free Trial

What is Sun Pharmaceuticals Industries Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Sun Pharmaceuticals Industries's accounts receivables for the quarter that ended in Dec. 2023 was ₹0 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Sun Pharmaceuticals Industries's Days Sales Outstanding for the quarter that ended in Dec. 2023 was 0.00.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Sun Pharmaceuticals Industries's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was ₹N/A.


Sun Pharmaceuticals Industries Accounts Receivable Historical Data

The historical data trend for Sun Pharmaceuticals Industries's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sun Pharmaceuticals Industries Accounts Receivable Chart

Sun Pharmaceuticals Industries Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Accounts Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 88,842.00 94,212.40 90,614.00 105,928.90 114,385.10

Sun Pharmaceuticals Industries Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 114,385.10 - 113,026.50 -

Sun Pharmaceuticals Industries Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Sun Pharmaceuticals Industries Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Sun Pharmaceuticals Industries's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0/121568.6*91
=0.00

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Sun Pharmaceuticals Industries's accounts receivable are only considered to be worth 75% of book value:

Sun Pharmaceuticals Industries's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0+0.75 * 0+0.5 * 0-N/A
-0-0)/2399.33
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Sun Pharmaceuticals Industries Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Sun Pharmaceuticals Industries's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Sun Pharmaceuticals Industries (BOM:524715) Business Description

Traded in Other Exchanges
Address
Western Express Highway, Sun House, Plot No. 201 B/1, Goregaon (East), Mumbai, MH, IND, 400 063
Sun Pharmaceuticals Industries Ltd is India's largest generic pharmaceutical manufacturer and the fourth largest in the world. The company's largest markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is primarily based in India.

Sun Pharmaceuticals Industries (BOM:524715) Headlines

No Headlines